WHWK Stock Analysis: Buy, Sell, or Hold?
WHWK - Whitehawk Therapeutics, Inc. Common Stock
$2.70
0.01 (0.37%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 17, 2026
Get Alerted When WHWK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: WHWK shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: WHWK shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: WHWK is currently trading at $2.70, which is considered fair relative to its 30-day fair value range of $2.55 to $2.81.
Technical Outlook: Technically, WHWK is in a strong uptrend. Immediate support is located at $2.60, while resistance sits at $3.05.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $4.50 (+67.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, WHWK is in a strong uptrend. Immediate support is located at $2.60, while resistance sits at $3.05.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $4.50 (+67.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$2.55 -
$2.81
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 67.3% below Wall St target ($4.50)
Fair Price Analysis
30-Day Fair Range
$2.55 -
$2.81
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$0.41
(15.1%)
Support & Resistance Levels
Support Level
$2.60
Resistance Level
$3.05
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.32
Wall Street Target
$4.50
(+67.3%)
Revenue Growth (YoY)
33.5%
Profit Margin
-108.6%
Last updated: January 31, 2026 1:02 AM ET
Data refreshes hourly during market hours. Next update: 2:02 AM
Data refreshes hourly during market hours. Next update: 2:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WHWK showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced WHWK Option Strategies
Professional options setups generated by AI based on today's WHWK price and gamma walls.